TABLE 1.
Baseline Characteristics of Subjects
| Celecoxib (n = 22) | Placebo (n = 18) | |
|---|---|---|
| Age (yrs), mean (SD) | 56.6 (10.1) | 59.3 (10.5) |
| Education (yrs), mean (SD) | 15.0 (1.7) | 15.5 (2.6) |
| Sex (%), female, number | 9 (41) | 6 (33) |
| Mini-mental state examination, mean (SD) | 29.2 (1.1) | 29.2 (0.9) |
| Hamilton rating scale for depression, mean (SD) | 2.9 (2.9) | 1.9 (2.2) |
| Hamilton rating scale for anxiety, mean (SD)a | 5.1 (4.6) | 3.6 (3.7) |
| WAIS full scale IQ, mean (SD) | 109.2 (9.0) | 112.6 (7.0) |
| Family history of dementia, n (%) | 4 (18.2) | 8 (44.4) |
| APOE-4 carriers, n (%)b | 6 (28.6) | 7 (41.2) |
a
One subject in the celecoxib group did not complete this scale.
b
APOE-4 status missing for one subject each from celecoxib and placebo groups.